Background. Noninvasive assessment of regional myocardial perfusion at rest and after stress is important for the objective evaluation of the effects of coronary artery disease and its response to therapy. Centers that do not have cyclotrons rely on generator-produced radioisotopes for assessment of regional myocardial perfusion with positron emission tomography (PET). The aim of the present study was to develop and implement an approach to quantify regional myocardial perfusion using copper(II) pyruvaldehyde bis-(N4-thiosemicarbazone) (PTISM) labeled with the generator-produced, positron-emitting radionuclide 62Cu (t1,2=9.7 minutes).
without regional disparities) such as patients with chest pain but angiographically normal coronary arteries, those with cardiac transplantation, and those with cardiomyopathies. Positron emission tomography (PET) has become invaluable for the noninvasive regional quantification of myocardial perfusion because of its ability to accurately delineate the distribution of positron-emitting radionuclides within the body.
Although perfusion can be measured accurately with cyclotron-produced flow tracers such as oxygen-15labeled water (H2l50)1-6 and '3N-ammonia,7,8 PET centers that do not have access to cyclotron-produced tracers rely on generator-produced 12Rb-chloride for estimation of flow. Although 82Rb has been used extensively and successfully in the detection of coronary artery disease9-'3 and, as shown recently by us, can be used with PET for quantification of regional myocardial blood flow using a two-compartment model,'4 the short half-life of this tracer (1.3 minutes) and its complex behavior in tissue'5-20 make 12Rb less than ideal for the quantification of myocardial perfusion. Thus, there is interest in the development of alternative generatorproduced perfusion tracers.
Our group has been studying the lipophilic compound copper(II) pyruvaldehyde N4-methylthiosemicarbazone (Cu-PTSM) (which can be labeled with several singlephoton as well as positron-emitting copper radionuclides) as a potential flow tracer. This lipophilic compound was originally studied in biological systems for its potential antineoplastic activity.2' The mechanism of copper entrapment in tumor cells has been shown to involve diffusion of the intact complex across the cell membrane with subsequent reduction of copper(II) to copper(I) by ubiquitous intracellular sulfhydryl groups. 22 In tumor cell models, the reduced copper is believed to bind nonspecifically to intracellular macromolecules, thereby becoming trapped. In biodistribution studies in rats, Green et al23'24 demonstrated that radiolabeled Cu-PTSM exhibited high heart-to-blood ratios, prolonged tissue retention, and rapid blood pool clearance. We recently demonstrated that the singlepass myocardial extraction fraction of radiolabeled Cu-PTSM is high in studies performed in isolated perfused rabbit hearts, and that once extracted, tracer is retained over a wide range of flows and physiological conditions. 25 In intact anesthetized dogs, although net myocardial uptake of radiolabeled Cu-PTSM was monotonically related to flow,26 in subsequent analysis of the data, myocardial extraction of Cu-PTSM was found to be nonlinear and inversely related to flow (unpublished observations). Thus, to estimate flow accurately, a mathematical approach must be used to decouple flow estimates from extraction. The aim of the present study was to develop and implement an approach to quantify regional myocardial perfusion noninvasively with Cu-PTSM labeled with the generator-produced positronemitter 62Cu (t1,2=9.7 minutes).
Methods

Experimental Protocol
All studies in experimental animals were performed under general anesthesia and conformed to the "Position of the American Heart Association on Research Animal Use." Dogs were sedated with 1 mg/kg morphine subcutaneously after an overnight fast and anesthetized with 12.5 mg/kg of thiopental and 72 mg/kg of a-chloralose administered intravenously. The dogs were intubated and ventilated with room air. Myocardial perfusion was evaluated during 21 flow states in 13 dogs. One dog was studied without any intervention. To evaluate low flow, in two dogs, myocardial ischemia was induced by placement of a thrombogenic coil in the left anterior descending coronary as described previously.27 These dogs were studied 2 hours after angiographically documented occlusion and restudied 2 hours after thrombolysis with tissue-type plasminogen activator (confirmed by repeat angiography). In 10 dogs, after anticoagulation with heparin, coronary stenosis of 50-70% diameter narrowing was induced by placement of an intracoronary plastic stenosis in the left anterior descending coronary artery as described previously.28 In six of these dogs, myocardial hyperemia was induced with intravenous dipyridamole (Persantine, a gift from Boehringer Ingelheim, Ridgefield, Conn.) infused at a Positron Emission Tomography Dogs were placed in a Plexiglas holder and positioned within PET VI, a positron emission tomograph that permits the simultaneous acquisition of seven transverse tomographic slices with a slice-to-slice separation of 1.44 cm, a slice thickness of 1.39 cm, and a reconstructed resolution of 12.0 mm (full width at half maximum). A transmission scan, necessary for attenuation correction, was obtained using an external ring of 6"Ge/68Ga. To compare flow estimates obtained with 62Cu-PTSM with those obtained with H2'5O, in 15 interventions in nine dogs, 20-30 mCi of H2150 was administered intravenously as a bolus over 3-5 seconds, and tomographic acquisition was performed for 90 seconds in 5-second frames. To delineate the blood pool, 20 mCi of 150-carbon monoxide (C'50) was delivered by inhalation, and tomographic acquisition was performed for 5 minutes. Because of half-life considerations, '5o was administered before 62Cu. In all dogs, after each intervention, 5-15 mCi of 62Cu-PTSM obtained from a 62Zn/62Cu generator as previously described was administered intravenously as a bolus over 3-5 seconds in a total volume of 5-10 ml.29 Details of the bombardment procedure used to produce 62Zn and for preparation of the 62Zn/62Cu generator have been previously described. 29, 30 The generator was prepared using 62Zn obtained from Mallinckrodt Medical, Inc. (St. Louis, Mo.) as previously described except that the generator eluant was decreased from 2 N HCl to 1.8 NaCI/0.2 N HCI. In addition, the buffer was changed from 3 N sodium acetate to 0.3 N, and the amount of H2-PTSM was increased from 1.5 jig to 5 jig. These minor alterations provided yields in excess of 90%, radiochemical purity based on thin-layer chromatography of greater than 95%, and breakthrough of 62Zn in the eluant of less than 0.001%. Tomographic acquisition was initiated at the time of administration of 62Cu-PTSM and continued for 20 minutes. Data were collected in 5-second frames for the first 90 seconds and in 30-second frames for the next 334 seconds. Collections then were made in 5-minute frames.
Analysis of Tomographic Data
Tomographic data were reconstructed by filtered back-projection into images of 100x100 picture elements (pixel), with each pixel representing 2.7 mm2. To obtain myocardial time-activity data from the tomographic reconstructions, three to four regions of interest per slice representing 2-6 cm3 were interactively placed on the midventricular reconstructions. Counts per pixel were calculated from each time frame for each defined region of interest.
Estimates of Myocardial Perfusion From Positron Emission Tomography Data
A weighted nonlinear least-squares technique31'32 was used to calculate regional myocardial perfusion from 162 regions of interest in 21 studies from 62Cu-PTSM tomographic data using the two-compartment model delineated in detail in the "Appendix."
After fixing the fractional volume of the first compartment (v) to 0.95 ml per milliliter and the tissue recovery coefficient (FMM) to 0.72 (for regions in the septal, dose of 0.14 mg/kg per minute for 4 minutes. lateral, or inferoposterior walls) or 0.61 (for regions in the anterior wall) (see "Appendix"), regional myocardial blood flow was estimated for all tissue regions along with kl, the forward rate of transport from compartment 1 to 2, and FBM, the blood-to-myocardium spillover factor. Data were collected for 20 minutes (and dynamically for 424 seconds); however, because 62Cu-PTSM is retained by the myocardium after initial extraction, 25 only the first 90 seconds of the data were used in the estimation of myocardial perfusion. The rationale for using only the first 90 seconds of data versus the complete 7 minutes of dynamic data was based on the fact that after 40-50 seconds, 62Cu tissue activity does not vary (see "Results"). Thus, all flow information is contained in the early part of the dynamic blood and tissue curves. Estimates of flow obtained using all of the dynamic data were not statistically different from flow estimated using only the first 90 seconds (see "Results"). Static 5-minute scans were collected for image display purposes.
To compare under the same physiological conditions the estimates of regional perfusion obtained with 62Cu-PTSM with those obtained with H2150, regional perfusion was estimated from H2`50 data using a one-compartment kinetic model described and validated previously."25 Estimates of perfusion were obtained from the same anatomic regions with both tracers.
Measurement of Blood Flow With Radiolabeled Microspheres
Myocardial perfusion estimated with PET was compared with measurements obtained with radiolabeled 15-,um microspheres administered concomitantly with tracer via a retrogradely placed left atrial catheter. While microspheres were administered, blood from a femoral artery was withdrawn at 10 ml/min with a constant withdrawal pump. For the six dogs in which myocardial hyperemia was induced with intravenous dipyridamole, two dogs received two sets of microspheres after intravenous dipyridamole; one at the time of H2`50 and another at the time of 62Cu-PTSM. Since hyperemic flows were not different between these two sets of spheres, all other dogs had only one set of microspheres injected between H2150 and 62Cu-PTSM.
There was an average of 10 minutes between the administration of H2`50 and 62Cu-PTSM. After the dogs were given an intravenous overdose of anesthesia and saturated potassium chloride, 10-20 transmural samples (approximately 1 g each) of myocardium from the anterior left ventricle and eight to 12 samples from normal posterolateral myocardium were obtained. Blood flow in these tissue samples was calculated with the standard reference technique.33 To register regional microsphere flows with regions of interest in tomographic images, transmural flows obtained from the anterior left ventricular samples (i.e., the myocardium subjected to ischemia, reperfusion, or distal to the stenosis) were averaged to generate an average "anterior" flow value, and those obtained from the normal posterolateral myocardium were averaged to generate "normal" flow. Thus, for each evaluation, two microsphere flow values were generated. Similarly, large regions of interest from the anterior and posterolateral myocardium were identified and averaged for all tomographic slices. Transmural flows were used because the spatial resolution of PET VI and the nongated data acquisition preclude tomographic estimation of subtransmural flows.
Measurement ofArterial Blood Radioactivity
The arterial input function, necessary for quantitation with the mathematical approach, was obtained by monitoring time-activity data from a catheter exteriorized from the thoracic aorta via the femoral artery. The total volume of the catheter was less than 1.5 ml, and the blood was allowed to flow freely from the catheter during data acquisition. The anticoagulated blood was reinfused into the dog at the end of the data collection. Measured flow rates were never less than 20 ml/min so that the maximum delay from the tip of the catheter to the probe was less than 5 seconds. Because of the high flow rates, dispersion was minimal. Radioactivity was detected with a collimated gamma scintillation probe, and data were recorded by a minicomputer for subsequent analysis. The detector was shielded by more than 4 inches of lead so that background radioactivity in the catheter was zero even after administration of 40 mCi of radioactivity into the intact dog. To correct for time discrepancies between the time of detection of activity by the probe and the time of arrival in the coronary artery and to scale probe counts to tomographic counts, decay-corrected 62Cu-PTSM and H2`50 arterial blood curves were fitted to curves obtained tomographically from a region of interest placed within the cavity at the center of a midventricular slice. A region in the left ventricular rather than the left atrial chamber was chosen for the time correction because it reflects more closely the time of arrival of tracer in the ascending aorta (and thus, the coronary artery).
Correction ofArterial Blood Radioactivity for Red Blood Cell-Associated 62Cu
We recently found that in experimental animals, after intravenous administration, label from administered Cu-PTSM associates rapidly and irreversibly with red blood cells, reducing the amount of Cu-PTSM in plasma and that available to tissues.34 When 67Cu-PTSM was added to human blood (hematocrit, 44%) in vitro, approximately 75% of the activity associated with plasma, whereas 25% partitioned into the erythrocytes. 35 This partitioning did not change with time. Addition of fresh (nonlabeled) erythrocytes to tracer in plasma established the same equilibrium as when the tracer was added to whole blood: 75% in plasma, 25% in erythrocytes. In contrast, sequential washes of labeled erythrocytes with fresh plasma did not reestablish the original equilibrium distribution, indicating that activity associated with erythrocytes is not available to the plasma (or for tissue extraction). Thus, to define an accurate input function, arterial blood must be corrected for erythrocyte binding.
In nine studies from five dogs, seven to 11 sequential blood samples were collected during the scanning period directly into tubes containing octanol. The tubes were rapidly vortexed and centrifuged, and the supernatant and precipitate were counted in a gamma well counter. The ratio of 62Cu in the alcohol phase to total activity was calculated for each blood sample. In studies performed in our laboratory using 'Cuor 67Cu-PTSM, radioactivity in the supernatant, alcohol phase was documented to be in the form of Cu-PTSM by thin-layer is uppermost, septum is to the right, andposterior is lowermost. Uptake oftracer is homogenous, and contrast between myocardium and both blood and lung is high. chromatography using silica plates eluted with ethanol. For each study, a monoexponential curve was fitted to the percent of octanol-extractable 62Cu-PTSM in blood over time, and the resulting analytical curve was used as the correction factor to correct whole blood activity for the association of the tracer with red blood cells. For those studies in which blood samples were not collected, an average correction factor was derived by fitting all data obtained from the nine studies to a single monoexponential curve (see "Results").
Human Studies
Although the main purpose of the study was to evaluate a mathematical approach for estimation of myocardial perfusion with 62Cu-PTSM, to evaluate the imaging characteristics and to test the feasibility of estimating myocardial perfusion with this tracer in human subjects, we measured regional myocardial perfusion at rest in five human volunteers with a low likelihood for coronary artery disease. The studies were approved by the Human Studies Committee of the Washington University School of Medicine and performed after written informed consent was obtained.
One subject was studied in Super PETT I36; all other subjects were evaluated in Super PET 3000-E, a new, high-count rate capability, whole-body tomograph. 37 Both permit simultaneous acquisition of seven transaxial slices.
After collection of attenuation data, 30-40 mCi of C`5O was administered by inhalation; after an interval of 30-60 seconds to allow for clearance of activity from the lungs, data were collected for 5 minutes. After a 5-10-minute interval to allow decay of activity of the tracer to baseline levels, 0.4 mCi/kg of H2,50 was injected as a bolus through a large-bore catheter inserted into an antecubital vein. After another interval of 5-10 minutes to permit decay of radioactivity from H215O, 0.2-0.24 mCi/kg of 62Cu-PTSM was intravenously injected as a bolus, and data were collected for up to 20 minutes. Data were reconstructed and analyzed analogously to that in experimental animals. For assessment of the input function, a small region of interest was placed within the left atrial blood pool. The arterial input function was corrected for red blood cell binding by evaluation of timed samples obtained from venous blood. Binding of 62Cu-PTSM to erythrocytes in venous blood should be greater than that in the arterial blood because of the increased time for interaction. Results Figure 1 shows four contiguous midventricular reconstructions obtained after administration of 62Cu-PTSM in a dog without intervention. Myocardial uptake is homogenous, and there is good contrast between the myocardium and both blood and lung. Figure 2 displays a single midventricular reconstruction obtained after administration of H215O, after 62Cu-PTSM, and again after reperfusion in a dog with an induced coronary artery occlusion. The concordant marked decrease in activity in the anterior region during occlusion reflects ischemia in the distribution of the left anterior descending coronary artery. After reperfusion, successful restoration of blood flow is apparent. Similar count rates were obtained for rest and dipyridamole studies (50-70,000 counts per slice per minute).
Myocardial Images
Measurement of 62Cu-PTSM Arterial Blood Activity Figure 3 shows the percent of octanol-extractable 62Cu-PTSM in blood with respect to total blood radioactivity as a function of time after administration of 62Cu-PTSM for the nine studies in which arterial blood samples were collected. The rate of disappearance of 62Cu-PTSM from blood was monoexponential. Figure 4 shows total blood activity and PTSM-associated activity after correcting for the association of the label with red blood cells. In dogs, by 1 minute after intravenous administration of 62Cu-PTSM, total blood radioactivity averaged approximately 9% of peak and by 2 minutes averaged approximately 6% of peak radioactivity. By 1 minute, 65% of blood radioactivity was associated with with respect to total 12Cu blood activity as a function of time after administration of 62Cu-PTSM in the nine studies in which arterial blood samples were analyzed. The rate of disappearance of62Cu-PTSMfrom blood is monoexponential. erythrocytes and by 2 minutes, more than 85% of the radioactivity was associated with erythrocytes. An average correction factor defined by the monoexponential equation shown in Figure 4 was used to estimate the concentration of 62Cu-PTSM in blood for those studies in which arterial blood samples were not collected. Figure 5 depicts time-activity curves obtained from dynamic PET reconstructions from a dog with induced coronary occlusion. The input curve (solid line) has been corrected for the binding of 62Cu to erythrocytes. After 1 minute, the amount of tracer in the tissue remains constant. Tissue activity in the ischemic region is 40% of that in the normal region.
Myocardial Perfusion Estimates
The correlation between myocardial blood flow estimated with the two-compartment model and values obtained with radiolabeled microspheres is shown in Figure 6 . Perfusion estimates with 62Cu-PTSM correlate well (r=0.95, p<0.001) with flow estimated with radiolabeled microspheres over a wide range of flows, although flow is slightly underestimated, as shown by a slope of 0.90. When the data were grouped into either low and normal flows (i.e., flows <1.5 ml/g per minute by microspheres) or high flows (flows >1.5 ml/g per minute), significant correlations were still observed between estimates obtained with 62Cu-PTSM and those obtained with microspheres (y=0.79x+0.15, r=0.80, p<O.001, n=31 and y=0.71x+1.0, r=0.88, p<0.001, n=13 for the low/normal and high flow samples, respectively).
Flow estimated using input curves corrected individually for erythrocyte binding of label ( Figure 6 , solid circles) were not different from those estimated using input curves corrected using the average correction for red cell binding (open circles). In the nine studies in which blood was assayed directly for 62Cu-PTSM radioactivity, flow estimated using individual corrections correlated closely with flows reestimated using the average correction factor shown in Figure 3 (y=1.08x+0.024, r=0.96, n=18 measurements). Table 1 summarizes the intrasubject variability of the 62Cu-PTSM flow estimates. The coefficient of variation of the regional flow values varied from 0% to 115% with a mean of 24±21%. 7A shows the correlation between regional myocardial flow estimated with H2`50 and those obtained with microspheres; Figure 7B shows the correlation between flows obtained with 62Cu-PTSM and those obtained with microspheres in 32 regions of interest during 15 different physiological states in the studies in which both tracers were administered. Whereas flows estimated with either tracer correlate well with microsphere flows, 62Cu-PTSM slightly underestimates flow, as shown by a slope of 0.84. The mean regional coefficient of variation for flows estimated with H250 was 22±13%; that of flows estimated with 62Cu-PTSM was 28±20%. To investigate whether the slight underestimation of flow observed using 62Cu-PTSM was partially due to fixing the myocardial recovery coefficient FMM we recalculated 62Cu-PTSM flows using individual regional values of FMM obtained from the H250 flow analysis. Figure 7C shows the correlation between flow obtained with 62Cu-PTSM and that obtained with microspheres after setting FMM for each region to the value obtained from the H2"5O analysis. When the individual value for FMM was used, the slope increased to 0.94, and the coefficient of variation of the flow estimates decreased from 28% to 21%, suggesting that the slight underestimation observed was due to use of fixed values of FMM.
To validate the assumption that 90 seconds of dynamic data is sufficient to accurately estimate flow, in seven different regions of interest from one study, regional flows were estimated using 7 minutes of dynamic data and were compared with estimates obtained using only 90 seconds of dynamic data. Mean differences between flow obtained with 90 seconds versus 7 minutes of data was 6+6%, and mean flows were equal (0.99+0.24 and 1.00±0.24 ml/g per minute, respectively). Estimates in normal regions were obtained from two to eight regions of interest placed in normal walls; those in anterior regions were obtained from one to three regions of interest. Two different regions with diverse flows were identifiable both by tomography and with microspheres in dogs 13 and 14 in the anterior myocardium. MSBF, microsphere blood flow (ml/g per minute); Reg, tomographic regions evaluated; Flow, estimated flow obtained with 62Cu-pyruvaldehyde N4-methylthiosemicarbazone; COV, coefficient of variation of flow estimates.
I
Human Studies
Although the main goal of the present study was to evaluate a quantitative approach for estimation for myocardial perfusion using`Cu-PTSM in experimental animals, we wanted to test the feasibility of the approach in human subjects. Accordingly, five healthy volunteers were evaluated using H2150 and 62Cu-PTSM.
A midventricular tomographic reconstruction from one volunteer is displayed in Figure 8 . Myocardial uptake of tracer was homogenous in all subjects. Furthermore, contrast between myocardium and either blood or lung was high, resulting in high-quality images as well as high-quality dynamic data. Counts were in the range of 30-60,000 counts per slice per minute. There were no significant differences between flow estimated with 62Cu-PTSM and flow estimated with H2150 (1.05 +0.36 and 0.96±0.28 ml/g per minute, respectively; n=32 individual regions of interest in five subjects; p=NS by paired t test). Furthermore, a high correlation was obtained between 62Cu-PTSM and H2150 estimates (y=l.llx-0.023, r=0.87, n=5). In addition, sampling of venous blood after administration of 62Cu-PTSM showed that much less radioactivity in blood was associated with erythrocytes compared with that observed in studies in dogs. In humans, by 1 minute after tracer administration, total arterial radioactivity (estimated from a region of interest placed within the left atrial cavity) averaged 10% of peak and was less than 5% of peak by 90 seconds. Analysis of venous blood indicated that by 1 minute, 92±5% of radioactivity is still extractable in octanol (as 62Cu-PTSM) and by 2 minutes, 87±5% was still in the form of 62Cu-PTSM. When myocardial perfusion was reestimated in the five subjects using the input function not corrected for erythrocyte binding, flow estimates correlated with those estimates obtained using the input function corrected for erythrocyte binding (y=l.OLx-0.05, r=1.0, n=5). To validate the assumption that 90 seconds of dynamic data suffices to accurately estimate flow in human subjects, regional flows were estimated in seven separate regions of interest from one study using 7 minutes of dynamic data and were compared with flow estimates obtained from 90 seconds of dynamic data. Mean differences between flow obtained with 90 seconds versus 7 minutes of data was 6±5%, and mean flows were 0.67±0.12 and 0.68±0.08 ml/g per minute, respectively, (p=NS).
Discussion
PET centers that do not have cyclotrons on site rely on generator-produced, positron-emitting radiotracers for the measurement of myocardial perfusion. Although 82Rb-chloride is the most widely used generator-produced tracer for this purpose and has been shown to enable detection of coronary artery disease with high sensitivity and specificity,9.10.12.13 quantification of regional myocardial perfusion with 82Rb has been more difficult to achieve because of its short physical half-life and its complex behavior in tissue. [14] [15] [16] [17] [18] [19] [20] The lipophilic Cu-PTSM is avidly extracted by the heart. In addition, once extracted by the heart, backdiffusion (efflux) is negligible. 25 The rapid blood pool clearance results in myocardial images of excellent quality. 26 Nonetheless, similar to other partially extractable flow tracers, studies in intact dogs have demonstrated that myocardial extraction of the 62Cu-PTSM is nonlinear and inversely related to flow. 26 Consequently, in order to quantify myocardial perfusion using 62Cu-PTSM, methods are needed to decouple flow from extraction.
The dynamic data obtained after bolus administration of Cu-PTSM are of high quality, facilitating estimates of myocardial perfusion with the compartmental model delineated in the "Appendix." Using this approach, regional myocardial perfusion correlated quite well with estimates of perfusion obtained with radiolabeled microspheres over a wide range of flows and physiological conditions (Figures 6 and 7) . Although estimates of perfusion with 62Cu-PTSM were slightly lower than values obtained with microspheres, the relation could be improved by the use of individual recovery coefficients, emphasizing the need for accurate partial volume correction. Nonetheless, it should be emphasized that even using fixed values of the tissue recovery coefficient, the correlation between flow estimated with 62Cu-PTSM and microspheres was quite close ( Figure 6 ).
Tomographic images in normal human volunteers were excellent (Figure 8 ), corroborating the recent demonstration by Beanlands et al, 38 and flows obtained with 62Cu-PTSM were similar to those obtained with H2150.
Technical Considerations
Accurate measurement of tracer activity in blood (the input function) is necessary for flow quantitation. Recent studies have demonstrated that, in experimental animals after administration of Cu-PTSM, some radioactivity associates with erythrocytes and cannot be extracted into octanol and is not in the form of PTSM. It has been shown that the erythrocyte-associated activity is not extractable by the heart. 35 To obtain an accurate input function, the arterial blood radioactivity must be corrected for non-PTSM-associated radioactivity. Although there was some variation when data from all dogs were plotted together (Figure 3 ), clearance of radioactivity from blood was always monoexponential in individual runs. Use of an analytical global correction scheme did not yield results different from those when individual blood curves were analyzed (Figure 6 ), suggesting that a global correction scheme should be sufficient. Since radiolabel binds irreversibly with red blood cells, plasma samples could be used to generate the corrected input function. Preliminary studies in humans suggest that the extent of erythrocyte binding is much less than that observed in dogs and has no significant influence on flow estimates. 39 Thus, for human studies, correction for the binding of tracer to erythrocytes is probably unnecessary. Use of 62Cu-PTSM for quantitation of myocardial perfusion requires the use of several parameters that are set to fixed values (see "Appendix"). Although error in estimation of flow can be induced by the use of inappropriate values, the use of fixed values is common in compartmental models in which numerous parameters are estimated. 8, 14 In addition, the demonstration that flow estimated with the two-compartment model using the fixed values of v and FMM correlate well with flow estimated with microspheres (in experimental studies) or with flows estimated with H2'50 (in human studies) suggest that the model configuration and choice of fixing the parameters are appropriate.
Flow at rest (1.05 +0.36) in the five human volunteers studied was slightly higher than those reported by others. This mainly is due to the fact that one of our human volunteers had a relatively high resting flow (1.42+0.23 and 1.63±0.40 estimated with H2150 and 62Cu-PTSM, respectively) compared with the rest of the group (H2"5O flow estimates, 0.84±0.15 and 62Cu-PTSM flow estimates, 0.90±0.19 ml/g per minute). Clinical Implications
The results of this study suggest that 62Cu-PTSM is an attractive alternative generator-produced, positronemitting radiotracer for the estimation of myocardial perfusion. Although centers with cyclotrons may prefer
The model parameters to be estimated are regional myocardial blood flow, F, (ml/g per minute); the forward rate of transport from compartment one to two, ki (min-1); and the fractional volume of distribution of the tracer in the first compartment, v (ml/ml). The measured quantities are PET tissue activity, CrPET(t), and the arterial blood activity, Ca(t).
Tissue recovery and blood-to-myocardial spillover fractions (FMM and FBM, respectively) must be either known a priori or estimated along with the model parameters. In preliminary simulations, we observed that regional perfusion could not be estimated accurately simultaneously with the four other parameters (kl, v, FMM, and FBM). Accordingly, v, the volume of the first compartment and the model parameter expected to vary the least, and FMM, the tissue recovery coefficient, were fixed to average values. A value of 0.95 was derived for estimates of v obtained from fitting tissue curves obtained from normal lateral regions to the model using flow values obtained from microspheres as a known parameter (0.95 +0.25, n=10). FMM was fixed to 0.72 in lateral, septal, and posterior walls and to 0.61 in anterior walls. These averages were computed in previous dog studies from our laboratory.2
The ability of the model configuration to estimate regional perfusion was investigated by the analysis of the covariance and correlation matrixes of the parameter estimates. The weak correlation of the flow parameter with the other two parameters, k, and FBM, and the relatively small standard error associated with each flow estimate indicated that the model configuration can estimate regional perfusion reliably.
